A22T (p.Ala22Thr) variant of MFN2 (Mitofusin-2)

A22T (p.Ala22Thr) in MFN2 (Mitofusin-2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.68 / 1. The record also includes population frequency data and structural context.

A22T (p.Ala22Thr) variant details